[go: up one dir, main page]

TWI878636B - Pharmaceutical composition comprising empagliflozin co-crystal - Google Patents

Pharmaceutical composition comprising empagliflozin co-crystal

Info

Publication number
TWI878636B
TWI878636B TW110145722A TW110145722A TWI878636B TW I878636 B TWI878636 B TW I878636B TW 110145722 A TW110145722 A TW 110145722A TW 110145722 A TW110145722 A TW 110145722A TW I878636 B TWI878636 B TW I878636B
Authority
TW
Taiwan
Prior art keywords
empagliflozin
crystal
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
TW110145722A
Other languages
Chinese (zh)
Other versions
TW202222322A (en
Inventor
金起賢
曹民官
金暋洙
朴信政
Original Assignee
韓商鐘根堂股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200170136A external-priority patent/KR20220080880A/en
Application filed by 韓商鐘根堂股份有限公司 filed Critical 韓商鐘根堂股份有限公司
Publication of TW202222322A publication Critical patent/TW202222322A/en
Application granted granted Critical
Publication of TWI878636B publication Critical patent/TWI878636B/en

Links

TW110145722A 2020-12-08 2021-12-07 Pharmaceutical composition comprising empagliflozin co-crystal TWI878636B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200170136A KR20220080880A (en) 2020-12-08 2020-12-08 Pharmaceutical composition comprising empagliflozin co-crystal
KR10-2020-0170136 2020-12-08

Publications (2)

Publication Number Publication Date
TW202222322A TW202222322A (en) 2022-06-16
TWI878636B true TWI878636B (en) 2025-04-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP4045480A4 (en) Pharmaceutical formulations
GB202008961D0 (en) Pharmaceutical composition
EP4132511A4 (en) Pharmaceutical compositions comprising meloxicam
EP3946316A4 (en) Cannabidiol pharmaceutical compositions
EP3613419A4 (en) Pharmaceutical composition containing indirubin derivative as active ingredient
EP4122483A4 (en) Oral pharmaceutical composition
EP3903786A4 (en) Novel compound and pharmaceutical composition comprising same for enhancing anticancer activity
EP4015001A4 (en) Oral pharmaceutical composition
EP3949967A4 (en) Solid pharmaceutical composition comprising tlr7 agonist
EP4190310A4 (en) Stable pharmaceutical preparation
EP3914234A4 (en) Pharmaceutical compositions
EP4058025A4 (en) Pharmaceutical compositions comprising ticagrelor
EP4230210A4 (en) Stable pharmaceutical composition
TWI878636B (en) Pharmaceutical composition comprising empagliflozin co-crystal
EP4175626A4 (en) Novel pharmaceutical compositions
AU2021413439A9 (en) Pharmaceutical composition for inhalation
EP4171529A4 (en) Topical pharmaceutical compositions
EP3920909A4 (en) Pharmaceutical compositions comprising meloxicam
EP4205765A4 (en) Stable pharmaceutical preparation
EP4197540A4 (en) Drug formulation containing sepetaprost
EP3950058A4 (en) Pharmaceutical composition having favorable stability
EP4079305A4 (en) Application of compound in drug preparation
EP4008353A4 (en) Pharmaceutical composition for otic administration
EP4338730A4 (en) Pharmaceutical composition
EP4176868A4 (en) Stable pharmaceutical composition